Ocugen, Inc. Announces Pricing of $22.5 Million Offering of Common Stock
Ocugen, Inc. Announces Pricing of $22.5 Million Offering of Common Stock GlobeNewswire January 21, 2026 MALVERN, Pa., Jan. 21, 2026 (GLOBE NEWSWIRE) — Ocugen, Inc. (Nasdaq: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced the pricing of its underwritten offering of 15,000,000 shares of its common stock at an offering […]